Faruqi & Faruqi recognized as one of the Top Law Firms representing plaintiffs (2009-2016), Lex Machina Securities Litigation Report 2017
Faruqi & Faruqi recognized as one of the Top Law Firms representing plaintiffs (2009-2016), Lex Machina Securities Litigation Report 2017 Click here to read the Law360 article. ...
Faruqi & Faruqi Obtains Significant Victory On Behalf of Consumers in Becerra et al. v. General Motors LLC
On March 10, 2017, the Honorable William Q. Hayes of the United States District Court for the Southern District of California denied, in part, Defendant's Motion to Dismiss in Becerra et al. v. General Motors LLC, No. 15-cv-02365. Judge Hayes found that ...
Faruqi & Faruqi, LLP Reaches Settlement On Behalf Of Investors In Acadia Pharmaceuticals Inc.
Faruqi & Faruqi, LLP is pleased to announce that on March 13, 2017, Lead Plaintiffs, on behalf of themselves and a class of all persons who purchased or otherwise acquired publicly-traded ACADIA common stock and/or call options in the United States or ...
Faruqi & Faruqi, LLP Reaches Settlement On Behalf Of Shareholders Of Geron Corporation
Faruqi & Faruqi is pleased to announce that on March 2, 2017, Lead Plaintiff Vinod Patel, on behalf of himself and a class of all persons who purchased Geron common stock between December 10, 2012 and March 11, 2014, reached a settlement with Geron Corporation, ...
Faruqi & Faruqi obtains Collective Certification on behalf of Aldi Store Managers
On February 22, 2017, the Honorable Andrew Baxter of the United States District Court for the Northern District of New York conditionally certified a collective action brought by Aldi Store Managers alleging the grocery chain misclassified them as exempt ...
Court Grants Class Certification to Direct Purchasers of Lidoderm in Antitrust Case and Appoints Faruqi & Faruqi Co-Lead Counsel
On February 21, 2017, the Honorable William H. Orrick of the United States District Court for the Northern District of California certified a class of direct purchasers of the pain medication patch Lidoderm in the antitrust case In re Lidoderm Antitrust ...
Court Grants Final Approval of Settlement in In re Dynavax Technologies Corporation Securities Litigation
On February 6, 2017, the Honorable Charles R. Breyer, United States District Judge for the Northern District of California, entered final approval of the settlement reached in In re Dynavax Technologies Corp. Sec. Litig., No: 3:13-CV-02796-CRB, for which ...
COURT APPOINTS FARUQI & FARUQI, LLP LEAD COUNSEL IN SECURITIES CLASS ACTION AGAINST GOPRO, INC.
On February 6, 2017, Senior District Judge Claudia Wilken of the United States District Court for the Northern District of California appointed Faruqi & Faruqi, LLP to serve as Lead Counsel in Bielousov v. GoPro, Inc., et al., No. 4:16-CV-06654-CW. For ...
James (Josh) M. Wilson and Adam Steinfeld made partners with the Firm
Faruqi & Faruqi is pleased to announce that Josh Wilson and Adam Steinfeld are now partners with the Firm. Josh continues to litigate in securities matters on behalf of investors nationwide. Adam continues to practice in the area of antitrust litigation. ...
Peter Kohn and Joseph T. Lukens were both honored with the designation of Super Lawyer for 2017
Peter Kohn and Joseph T. Lukens, Partners of Faruqi & Faruqi, LLP, were both honored with the designation of Super Lawyer in Pennsylvania for the year 2017. Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who ...
Faruqi Firm Files Antitrust Case Over ADHD Medication
On January 11, 2017, Faruqi & Faruqi, LLP filed a federal antitrust class action case against brand and generic manufacturers of ADHD drug, Intuniv. The complaint alleges that the companies, Shire and Actavis, violated the antitrust laws by entering into ...
Faruqi & Faruqi files slack-fill case against Nestle’ U.S.A., Inc.
On January 3, 2017, Faruqi & Faruqi, LLP filed a federal consumer class action case against Nestle' U.S.A., Inc. for allegedly under-filling its opaque theater box Raisinets products to the detriment of unsuspecting consumers. The case was filed in the ...
Faruqi & Faruqi files cases against generic drug manufacturers
On December 27 & 28, 2016, Faruqi & Faruqi, LLP filed several cases against generic drug manufacturers for allegedly conspiring to raise the prices of generic divalproex ER, desonide, pravastatin, econazole, fluocinonide, levothyroxine, propranolol, and ...
Faruqi & Faruqi, LLP announces preliminary approval of settlement in In re Dynavax Technologies Corporation Securities Litigation
Faruqi & Faruqi LLP is pleased to announce that the Court has preliminarily approved a settlement in In re Dynavax Technologies Corp. Sec. Litig., Case No: 3:13-CV-02796-CRB. The settlement provides for a cash payment of $4.5 million in exchange for plaintiffs' ...
Faruqi & Faruqi, co-Lead Counsel, Obtains a Significant Victory on Behalf of Investors Against Comverge Inc.’s Former Board of Directors
On October 31, 2016, the Honorable Tamika Montgomery-Reeves, Vice Chancellor of the Delaware Court of Chancery, denied a motion for summary judgment filed by the former board of directors (the "Board") of Comverge Inc. ("Comverge"). In denying summary ...
Faruqi & Faruqi, Lead Counsel, Obtains Final Approval of $3,000,000 Common Fund in In re Mavenir Systems, Inc. Stockholders Litigation
On October 12, 2016, the Honorable Tamika Montgomery-Reeves, Vice Chancellor of the Delaware Court of Chancery, granted final approval of the proposed settlement in In re Mavenir Systems, Inc. Stockholders Litigation, C.A. No. 10757-VCMR. Faruqi & Faruqi, ...
Court Grants Final Approval of Settlement in Chelsea Therapeutics International, Ltd. Securities Litigation
The Honorable Max O. Cogburn, Jr., United States District Judge for the Western District of North Carolina entered final approval of the settlement reached in McIntyre v. Chelsea Therapeutics International, Ltd., et al., No. 3:12-CV-00213-MOC-DCK (W.D.N.C.) ...
Faruqi & Faruqi, LLP Obtains Significant Victory On Behalf Of Investors Against ACADIA Pharmaceuticals Inc.
On September 19, 2016, United States District Judge Barry Ted Moskowitz denied a motion to dismiss filed by ACADIA Pharmaceuticals Inc. ("ACADIA"), former Chief Executive Officer ("CEO") Uli Hacksell, current President and CEO Stephen R. Davis, and former ...
Faruqi & Faruqi, LLP announces appointment as co-lead counsel and preliminary approval of settlement in In re Boulder Brands, Inc. Stockholder Litigation
Faruqi & Faruqi LLP is pleased to announce its appointment as co-lead counsel and preliminary approval of a settlement in In re Boulder Brands, Inc. Stockholder Litigation, Lead Case No: 2015-CV-01349 (consolidated with Case No. 2015-CV-31474). The settlement ...
Faruqi & Faruqi, LLP Announces Preliminary Court Approval of Settlement in McIntyre v. Chelsea Therapeutics International, Ltd., et al.
Faruqi & Faruqi LLP is pleased to announce the Court's preliminary approval of a settlement in MacIntyre v. Chelsea Therapeutics International, Ltd., et al., Case No. 3:12-CV-213-MOC-DCK (W.D.N.C.). The settlement provides for $5,500,000 in cash to be ...